Bayesian Hierarchical Models for Meta-Analysis of Quality-of-Life Outcomes: An Application in Multimorbidity

Susanne Schmitz*, Tatjana T. Makovski, Roisin Adams, Marjan van den Akker, Saverio Stranges, Maurice P. Zeegers

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

26 Downloads (Pure)

Abstract

Background Health-related quality of life (HRQoL) is a key outcome in cost-utility analyses, which are commonly used to inform healthcare decisions. Different instruments exist to evaluate HRQoL, however while some jurisdictions have a preferred system, no gold standard exists. Standard meta-analysis struggles with the variety of outcome measures, which may result in the exclusion of potentially relevant evidence. Objective Using a case study in multimorbidity, the objective of this analysis is to illustrate how a Bayesian hierarchical model can be used to combine data across different instruments. The outcome of interest is the slope relating HRQoL to the number of coexisting conditions. Methods We propose a three-level Bayesian hierarchical model to systematically include a large number of studies evaluating HRQoL using multiple instruments. Random effects assumptions yield instrument-level estimates benefitting from borrowing strength across the evidence base. This is particularly useful where little evidence is available for the outcome of choice for further evaluation. Results Our analysis estimated a reduction in quality of life of 3.8-4.1% per additional condition depending on HRQoL instrument. Uncertainty was reduced by approximately 80% for the instrument with the least evidence. Conclusion Bayesian hierarchical models may provide a useful modelling approach to systematically synthesize data from HRQoL studies.

Original languageEnglish
Pages (from-to)85–95
Number of pages11
JournalPharmacoeconomics
Volume38
Issue number1
Early online date4 Oct 2019
DOIs
Publication statusPublished - Jan 2020

Keywords

  • PREFERENCE-BASED MEASURE
  • HEALTH-CARE UTILIZATION
  • PSYCHOMETRIC PROPERTIES
  • SF-6D
  • PREVALENCE
  • IMPACT
  • EQ-5D
  • VALUATION
  • MORBIDITY
  • FRAMEWORK

Cite this